New recommendations in the care of pediatric and adolescent patients with tuberculosis Official opinion of the Children's Pulmonology Society ČLS JEP and the Society for Pneumology and Phthisiology ČLS JEP

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F24%3A10001343" target="_blank" >RIV/00064190:_____/24:10001343 - isvavai.cz</a>

Result on the web

<a href="https://doi.org/10.55095/CSPediatrie2024/031" target="_blank" >https://doi.org/10.55095/CSPediatrie2024/031</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.55095/CSPediatrie2024/031" target="_blank" >10.55095/CSPediatrie2024/031</a>

Result language

angličtina

Original language name

New recommendations in the care of pediatric and adolescent patients with tuberculosis Official opinion of the Children's Pulmonology Society ČLS JEP and the Society for Pneumology and Phthisiology ČLS JEP

Original language description

The new recommendations are a follow-up to the 2012 Standard treatment guidelines(1) and the 2016 special issue of Czech-Slovak Paediatrics dedicated to tuberculosis (TB).(2) The present document reflects the new recommendations(3) of the World Health Organization (WHO), which has long been seeking new strategies for optimal treatment of paediatric and adolescent patients, as more than 10 million people worldwide develop TB annually, including 1.2 million children.(4) In the Czech Republic, TB remains a rare disease, with an incidence of 3.6/100,000 in 2022.(5) Childhood TB mirrors the trend of adult TB. Between 2010- 2020, the trend was downward. Even the change in vaccination strategy in 2010 did not change this trend.(6) From 2021, we observe a slight increase in paediatric TB cases. In 2023, 29 children developed TB (Figure 1). The increase in paediatric TB cases, including treatment-resistant forms, makes it imperative to update recommendations for diagnosis and treatment in line with global trends. In particular, the main changes to the recommended approach relate to shortening treatment of uncomplicated TB in children aged 3-16 years to 4 months. There are also newly defined groups of drug-resistant (DR) TB and a new strategy for their treatment, which includes the administration of bedaquiline and delamanid. The introduction of TB preventive therapy for contacts of DR-TB is also innovative. (C) 2024, Czech Medical Association J.E. Purkyne. All rights reserved.c

Czech name

—

Czech description

—

Type

J_SC - Article in a specialist periodical, which is included in the SCOPUS database

CEP classification

—

OECD FORD branch

30203 - Respiratory systems

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2024

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Československá pediatrie

ISSN

0069-2328

e-ISSN

—

Volume of the periodical

79

Issue of the periodical within the volume

neuveden

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

11

Pages from-to

25-35

UT code for WoS article

—

EID of the result in the Scopus database

2-s2.0-85202843360